← Insider buys
MCRB

Seres Therapeutics, Inc. · Healthcare

Insider Matthew R. Henn sold $2.5M of Seres Therapeutics, Inc.

Sold$2,482,309
$27.04Price
91,812Shares
−100%Stake

What MCRB did after the filing

Prices for MCRB after this filing aren't in yet.

Traded Tue, Dec 1. Filed Thu, Dec 3, 11:05 AM ET, during the session. Not investment advice.